MedPath

山西普德药业有限公司

Ownership
-
Established
1995-09-13
Employees
-
Market Cap
-
Website
http://www.pudepharma.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

289

NMPA:289

Drug Approvals

Bortezomib for Injection

Product Name
注射用硼替佐米
Approval Number
国药准字H20253217
Approval Date
Jan 14, 2025
NMPA

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20249672
Approval Date
Dec 1, 2024
NMPA

Roxatidine Acetate Hydrochloride for Injection

Product Name
注射用盐酸罗沙替丁醋酸酯
Approval Number
国药准字H20249167
Approval Date
Oct 22, 2024
NMPA

Compound Potassium Hydrogen Phosphate Injection

Product Name
复合磷酸氢钾注射液
Approval Number
国药准字H20094204
Approval Date
Oct 11, 2024
NMPA

Dipotassium Hydrogen Phosphate

Product Name
磷酸氢二钾
Approval Number
国药准字H20090368
Approval Date
Oct 11, 2024
NMPA

Iron Sucrose for Injection

Product Name
注射用蔗糖铁
Approval Number
国药准字H20090367
Approval Date
Oct 11, 2024
NMPA

Potassium Dihydrogen Phosphate

Product Name
磷酸二氢钾
Approval Number
国药准字H20090369
Approval Date
Oct 11, 2024
NMPA

Voriconazole for Injection

Product Name
注射用伏立康唑
Approval Number
国药准字H20244553
Approval Date
Jul 30, 2024
NMPA

Ropivacaine Mesylate for Injection

Product Name
注射用甲磺酸罗哌卡因
Approval Number
国药准字H20090271
Approval Date
Jun 26, 2024
NMPA

Ropivacaine Hydrochloride Injection

Product Name
盐酸罗哌卡因注射液
Approval Number
国药准字H20193218
Approval Date
Jun 26, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 29
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.